Cargando…

High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome

BACKGROUND: Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder with different nutritional phases from suckling deficit with failure to thrive to early onset of obesity. Hyperghrelinemia has been described in PWS long before the development of obesity. Ghrelin is found in both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beauloye, Veronique, Diene, Gwenaelle, Kuppens, Renske, Zech, Francis, Winandy, Coralie, Molinas, Catherine, Faye, Sandy, Kieffer, Isabelle, Beckers, Dominique, Nergårdh, Ricard, Hauffa, Berthold, Derycke, Christine, Delhanty, Patrick, Hokken-Koelega, Anita, Tauber, Maithé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855494/ https://www.ncbi.nlm.nih.gov/pubmed/27146407 http://dx.doi.org/10.1186/s13023-016-0440-0

Ejemplares similares

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome
por: Kuppens, R. J., et al.
Publicado: (2015)

French database of children and adolescents with Prader-Willi syndrome
por: Molinas, Catherine, et al.
Publicado: (2008)

Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
por: Bar, Céline, et al.
Publicado: (2017)

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022)

Equivocal expression of emotions in children with Prader-Willi syndrome: what are the consequences for emotional abilities and social adjustment?
por: Famelart, Nawelle, et al.
Publicado: (2020)

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
por: Allas, Soraya, et al.
Publicado: (2018)

Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2021)

What underlies emotion regulation abilities? An innovative programme based on an integrative developmental approach to improve emotional competencies: Promising results in children with Prader–Willi syndrome
por: Famelart, Nawelle, et al.
Publicado: (2022)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome
por: Eddiry, Sanaa, et al.
Publicado: (2021)

Causes of death in Prader-Willi syndrome: lessons from 11 years’ experience of a national reference center
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2019)

Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients
por: Tauber, Maïthe, et al.
Publicado: (2011)

A study of voice and non-voice processing in Prader-Willi syndrome
por: Strenilkov, Kuzma, et al.
Publicado: (2020)

Face processing and exploration of social signals in Prader-Willi syndrome: a genetic signature
por: Debladis, Jimmy, et al.
Publicado: (2019)

Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients
por: Clerc, Alice, et al.
Publicado: (2021)

Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
por: Damen, Layla, et al.
Publicado: (2020)

Food socialization of children with Prader-Willi syndrome: an interdisciplinary problematization
por: Rochedy, Amandine, et al.
Publicado: (2023)

Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Atypical 15q11.2-q13 Deletions and the Prader-Willi Phenotype
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Behavioral profile of adults with Prader-Willi syndrome: correlations with individual and environmental variables
por: Jauregi, Joseba, et al.
Publicado: (2013)

Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial
por: Kuppens, R. J., et al.
Publicado: (2016)

Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients
por: Coupaye, Muriel, et al.
Publicado: (2021)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

Reduced Cortical Complexity in Children with Prader-Willi Syndrome and Its Association with Cognitive Impairment and Developmental Delay
por: Lukoshe, Akvile, et al.
Publicado: (2014)

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin
por: Damen, Layla, et al.
Publicado: (2020)

The transition from pediatric to adult care in individuals with Prader-Willi syndrome
por: Poitou, Christine, et al.
Publicado: (2022)

Divergent structural brain abnormalities between different genetic subtypes of children with Prader–Willi syndrome
por: Lukoshe, Akvile, et al.
Publicado: (2013)

Evidence for Accelerated Biological Aging in Young Adults with Prader–Willi Syndrome
por: Donze, Stephany H, et al.
Publicado: (2019)

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
por: Deal, Cheri L., et al.
Publicado: (2013)

Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader–Willi syndrome, Bardet–Biedl syndrome and craniopharyngioma versus anorexia nervosa
por: Vlaardingerbroek, H, et al.
Publicado: (2021)

Physical Activity in Patients with Prader-Willi Syndrome—A Systematic Review of Observational and Interventional Studies
por: Bellicha, Alice, et al.
Publicado: (2021)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome
por: Mosbah, Helena, et al.
Publicado: (2021)

SAT-446 No Central Adrenal Insufficiency Found in Adults with Prader-Willi Syndrome Tested by Multiple-Dose Metyrapone Test
por: Davidse, Kirsten, et al.
Publicado: (2019)

Acute stress response of the HPA-axis in children with Prader-Willi syndrome: new insights and consequences for clinical practice
por: Grootjen, Lionne N., et al.
Publicado: (2023)

Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome
por: Lukoshe, Akvile, et al.
Publicado: (2017)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Impact of Deprivation on Obesity in Children with PWS
por: Grolleau, Sabrina, et al.
Publicado: (2022)

Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome
por: Beauloye, Veronique, et al.
Publicado: (2015)

Computer-aided facial analysis as a tool to identify patients with Silver–Russell syndrome and Prader–Willi syndrome
por: Ciancia, Silvia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kqgqt82o4kpuql0vbk60id57h5